Latest

PSP

Featured Genetics Neurology Neuroscience

·May 19, 2021·6 min read

New Insight Into Protein Production in Brain Could Help Tackle Dementia

Researchers have identified a layer of genetic material involved in controlling the production of tau in the brain. The material is part of a larger family of non-coding genes that regulate and control other brain proteins associated with neurodegenerative disorders, such as Alzheimer's disease, Parkinson's, and PSP. The findings could lead to the development of new therapeutics to treat a range of neurodegenerative disorders.

Featured Genetics Neurology Neuroscience Open Neuroscience Articles

·January 5, 2020·5 min read

Up to 10,000 people could be living with rare neurological disorders

Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS), two atypical parkinsonian syndromes, may be twice as common as previously believed, researchers report.

Featured Neurology Neuroscience

·August 12, 2019·5 min read

Alzheimer’s disease destroys neurons that keep us awake

Tau accumulations disrupt wake-promoting neurons. The findings help explain why day-time napping and sleep disruptions are often reported in Alzheimer's patients.

Featured Genetics Neurology Neuroscience

·July 9, 2019·4 min read

Sorting protein in neurons defends against neurodegenerative disease

VPS35 is a novel critical component of tau metabolism and the pathology of neurodegenerative diseases.

Featured Neurology

·February 23, 2018·3 min read

Simple Walking Test May Help Diagnose Dementia

Researchers report a simple walking test may help doctors to accurately diagnose the onset of dementia.

Featured Neurology

·January 5, 2018·4 min read

How Alzheimer’s Spreads Through the Brain

Researchers investigate how toxic proteins associated with Alzheimer's disease spread throughout the brain.

Neurology Neuroscience Neuroscience Business

·November 4, 2017·7 min read

Cortice Biosciences Announces Presentation of Results from Placebo-Controlled Phase 1 Clinical Trials Evaluating TPI 287 for Treatment of Alzheimer’s Disease and Related Tauopathies

Cortice Biosciences announced today results from placebo-controlled, double-blinded Phase 1 studies evaluating TPI 287, a brain penetrable microtubule stabilizing agent, for the treatment of Alzheimer’s disease, progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS).